Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the neglected tropical diseases diagnosis market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for neglected tropical diseases diagnosis market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of neglected tropical diseases diagnosis market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Neglected Tropical Diseases Diagnosis Market Categorization:

The neglected tropical diseases diagnosis market was categorized into five segments, namely disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli Ulcer, Yaws, Lymphatic, Filariasis, Taeniasis/Cysticercosis,Foodborne Trematodiases, Echinococcosis, Chagas Disease, Dracunculiasis, African Trypanosomiasis, Soil-transmitted Helminth Infections, Onchocerciasis, Schistosomiasis, Scabies and Other Ectoparasites, Snakebite Envenoming, Leishmaniasis), diagnostic method (Conventional Method, Molecular/Modern Method), service type (Centralized Service, POC Service), end-use (Clinical Labs, Hospitals /Clinics, Home Healthcare), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The neglected tropical diseases diagnosis market was segmented into disease, diagnostic method, service type, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The neglected tropical diseases diagnosis market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twelve countries, namely, the U.S.; Canada; the UK.; Germany; China; India; Indonesia; Malaysia; Brazil; Colombia; Venezuela; Nigeria.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Neglected tropical diseases diagnosis market companies & financials:

The neglected tropical diseases diagnosis market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• F. HOFFMANN-LA ROCHE LTD - F. Hoffmann-La Roche Ltd., established in 1896 and based in Switzerland, functions through two main divisions: pharmaceuticals and diagnostics. The pharmaceuticals division specializes in areas such as oncology, infectious diseases, ophthalmology, immunology, and neuroscience, and is a prominent supplier of anticancer drugs. As of December 2020, the company employed 101,465 individuals. It operates in over 150 countries and its key subsidiaries include Genentech, Inc., Chugai Pharmaceutical Co., Ltd., Flatiron Health, Inc., Ventana Medical Systems, Inc., and mySugr GmbH.

• ABBOTT - Abbott, a company established in 1888 and based in the U.S., operates in four main areas: pharmaceuticals, devices, nutrition, and diagnostics. It has a global footprint, with facilities for research, manufacturing, sales, and distribution in over 150 countries. The pharmaceutical division provides generic medicines for various conditions including pain, fever, migraine, inflammation, pancreatic disorders, and hypertension, as well as cardiovascular, and metabolic products, and vaccines. The diagnostics division supplies reagents and tests for a range of uses. Abbott’s diagnostic technologies encompass polymerase chain reaction, fluorescence in situ hybridization, and DNA & RNA sequencing. The company’s immunoassays and clinical chemistry assays are utilized for diagnosing conditions such as cancer, infectious diseases, cardiovascular diseases, fertility issues, and for therapeutic drug monitoring. Globally, Abbott employs more than 109,000 individuals.

• THERMO FISHER SCIENTIFIC, INC. - Thermo Fisher Scientific, Inc., a global provider of scientific equipment, analytical instruments, and other laboratory apparatus, was established in 1956 and is based in the U.S. The company’s operations span across several sectors: pharmaceutical & biotechnology, industrial & applied research, diagnostics & healthcare, and academic & government. It offers a variety of products, including chromatographs, Erlenmeyer flasks, gene sequencers & spectrometers, clinical analytical tools, and diagnostic testing products. Serving over 400,000 customers worldwide, Thermo Fisher Scientific operates under several brands such as Applied Biosystem, Fisher Scientific, Thermo Scientific, Unity Lab Services, and Invitrogen. The company’s key offerings encompass molecular biology reagents, instruments, antibodies, protein biology reagents, and cell imaging & analysis instruments. Thermo Fisher Scientific has a global workforce of more than 75,000 employees.

• ZEPTOMETRIX - Established in 1999, ZeptoMetrix is recognized for its production and distribution of an expanding array of reagents & kits, which include ELISAs, select antibodies, HIV p24 antigen, and Western Blots. The company offers a comprehensive selection of panels for verification assessment and molecular & serological controls, which support research and quality assurance processes throughout the development and commercialization of diagnostic assays. The company’s corporate offices, R&D, and operations, encompassing immunology, microbiology, & molecular, are based in New York. Meanwhile, the primary production, assembly/packaging, distribution, bio-repository management, and customer support are housed in the FDA-registered facility situated in Franklin, Massachusetts.

• INBIOS INTERNATIONAL, INC. - Established in 1996, InBios International, Inc., a leading biotechnology firm based in the U.S., is committed to enhancing global health outcomes by offering solutions that are accurate, user-friendly, and affordable. The company’s expertise lies in the creation, development, and production of immunodiagnostic devices for infectious diseases. It has pioneered the development of rapid and ELISA-based diagnostic products for infectious diseases. The company’s product range includes FDA-approved ELISA kits for the dengue virus, Zika virus, and West Nile, along with rapid test kits for leishmaniasis and Chagas disease.

• GENOME DIAGNOSTICS PVT. LTD. - Genome Diagnostics Pvt. Ltd. is an India-based molecular diagnostics company that is focused on providing product quality, adoption of ethical production, and product development procedures. The company’s product portfolio has a wide variety of RT-PCR kits in the global market. With the introduction of novel products and technologies, the company has set the goal to become one of the leading players in the molecular diagnostic kits market.

• OMEGA DIAGNOSTICS GROUP PLC - Omega Diagnostics Group PLC is a company that specializes in providing unique products to its Health & Wellbeing and Global Health divisions, primarily in the immunoassay and in vitro diagnostics sectors. In the Health & Wellbeing division, the company offers a range of food intolerance tests, including Food Detective (point-of-care), Food Print (Microarray), ELISA, and CNS Lab Service, all of which are provided through Cambridge Nutritional Sciences (CNS). In the Global Health division, the company has partnered with the Burnet Institute to create VISITECT CD4, a quick, convenient, and affordable CD4 test for HIV patients. This test aims to enhance the availability of crucial diagnostics in low- and middle-income countries by enabling its use in decentralized settings.

• CORIS BIOCONCEPT SPRL - Coris BioConcept, a company based in Belgium and founded in 1996, is known for its expertise in the creation, manufacturing, and distribution of quick diagnostic kits. These kits are designed to detect gastrointestinal, human respiratory, and bloodborne pathogens (including viruses, bacteria, and parasites), as well as markers of antibiotic resistance. The company offers custom test development and contract manufacturing as part of its services. With a presence in over 80 countries spanning Asia Pacific, Europe, Latin America, and Africa, the company is a global player. To develop innovative solutions, Coris BioConcept frequently collaborates with Belgian and European Research Institutes, laboratories, and businesses.

• OSCAR MEDICARE PVT LTD. - Oscar Medicare Pvt. Ltd., an in vitro diagnostics company based in India, excels in the research and development, production, and marketing of a variety of products including rapid tests, serology kits, ELISA kits, biochemistry reagents, and hematology reagents kits, among others. The company boasts an internal R&D facility dedicated to creating new products for both the Indian and international markets. The company’s products have gained popularity in the market due to their superior quality, affordability, easy accessibility, and outstanding customer service. The company’s sales team is active throughout India, working to broaden the network and offer post-sales services, supported by a network of over 250 distributors in India and other countries. The company’s products, which are registered and exported to countries such as South Africa, Angola, Mozambique, Kenya, Ghana, South Sudan, Malawi, Mauritania, Trinidad and Tobago, Oman, Saudi Arabia, Bhutan, Bangladesh, Nepal, and the Philippines, among others, have a global reach.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Neglected Tropical Diseases Diagnosis Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Neglected Tropical Diseases Diagnosis Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.